A recent report reveals that Mcl-1 is overexpressed in about 50% of HCC tissues [1], suggesting that Mcl-1 may be a valuable oncogenic and/or therapeutic target of HCC. This evidence concerns the gene MCL1 and hepatocellular carcinoma.